[1] Lai Ch-Ch, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 55: 105924.

[2] Zaidi AK, Singh RB. Epidemiology of COVID-19. Prog Mol Biol Transl Sci 2024; 202: 25–38.

[3] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.

[4] Cheung CY, Poon LL, Ng IH, Luk W, Sia S-F, Wu MH, et al. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: Possible relevance to pathogenesis. J Virol 2005; 79: 7819–7826.

[5] Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, Peacock SJ, et al. SARS-CoV-2 variant biology: Immune escape, transmission and fitness. Nat Rev Microbiol 2023; 21: 162–177.

[6] Saxena SK, Kumar S, Ansari S, Paweska JT, Maurya VK, Tripathi AK, et al. Transmission dynamics and mutational prevalence of the novel severe acute respiratory syndrome coronavirus-2 omicron variant of concern. J Med Virol 2022; 94: 2160–2166.

[7] Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 2020; 5: 562–569.

[8] Wang Z, Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, Leydig and Sertoli cells. Cells 2020; 9: 920.

[9] Bermas BL. Paternal safety of anti-rheumatic medications. Best Pract Res Clin Obstet Gynaecol 2020; 64: 77–84.

[10] Stanley KE, Thomas E, Leaver M, Wells D. Coronavirus disease-19 and fertility: Viral host entry protein expression in male and female reproductive tissues. Fertil Steril 2020; 114: 33–43.

[11] Roychoudhury S, Das A, Jha NK, Kesari KK, Roychoudhury S, Jha SK, et al. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health. Open Biol 2021; 11: 200347.

[12] Xu J, Qi L, Chi X, Yang J, Wei X, Gong E, et al. Orchitis: A complication of severe acute respiratory syndrome (SARS). Biol Reprod 2006; 74: 410–416.

[13] Dutta S, Sengupta P. SARS-CoV-2 and male infertility: Possible multifaceted pathology. Reprod Sci 2021; 28: 23–26.

[14] Falahieh FM, Zarabadipour M, Mirani M, Abdiyan M, Dinparvar M, Alizadeh H, et al. Effects of moderate COVID-19 infection on semen oxidative status and parameters 14 and 120 days after diagnosis. Reprod Fertil Dev 2021; 33: 683–690.

[15] Holtmann N, Edimiris P, Andree M, Doehmen C, Baston-Buest D, Adams O, et al. Assessment of SARS-CoV-2 in human semen: A cohort study. Fertil Steril 2020; 114: 233–238.

[16] Edenfield RC, Easley IV ChA. Implications of testicular ACE2 and the renin: Angiotensin system for SARS-CoV-2 on testis function. Nat Rev Urol 2022; 19: 116–127.

[17] Björndahl L, Brown JK. The sixth edition of the WHO laboratory manual for the examination and processing of human semen: Ensuring quality and standardization in basic examination of human ejaculates. Fertil Steril 2022; 117: 246–251.

[18] Che B-W, Chen P, Yu Y, Li W, Huang T, Zhang W-J, et al. Effects of mild/asymptomatic COVID-19 on semen parameters and sex-related hormone levels in men: A systematic review and meta-analysis. Asian J Androl 2023; 25: 382–388.

[19] Stanworth RD, Jones TH. Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging 2008; 3: 25–44.

[20] Lukassen S, Chua RL, Trefzer T, Kahn NC, Schneider MA, Muley T, et al. SARS-CoV-2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells. EMBO J 2020; 39: e105114.

[21] Huang C, Ji X, Zhou W, Huang Z, Peng X, Fan L, et al. Coronavirus: A possible cause of reduced male fertility. Andrology 2021; 9: 80–87.

[22] Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open 2020; 3: e208292.

[23] Donders GG, Bosmans E, Reumers J, Donders F, Jonckheere J, Salembier G, et al. Sperm quality and absence of SARS-CoV-2 RNA in semen after COVID-19 infection: A prospective, observational study and validation of the Sperm COVID test. Fertil Steril 2022; 117: 287–296.

[24] Hashemitabar M, Heidari E, Orazizadeh M, Sabbagh S, Afrough M, Dastoorpoor M, et al. Cytochrome C oxidase 6B2 reflects the mitochondrial status through the oxidative phosphorylation. Iran Red Crescent Med J 2018; 20: 10.

[25] Lauritsen MP, Kristensen TL, Hansen CB, Schneider UV, Talbot AL, Skytte AB, et al. The impact of acute SARS-CoV-2 on testicular function including insulin-like factor 3 (INSL3) in men with mild COVID-19: A longitudinal study. Andrology 2024; 12: 437–446.

[26] Rao M, Zhao X-L, Yang J, Hu S-F, Lei H, Xia W, et al. Effect of transient scrotal hyperthermia on sperm parameters, seminal plasma biochemical markers, and oxidative stress in men. Asian J Androl 2015; 17: 668–675.

[27] Erbay G, Sanli A, Turel H, Yavuz U, Erdogan A, Karabakan M, et al. Short-term effects of COVID-19 on semen parameters: A multicenter study of 69 cases. Andrology 2021; 9: 1060–1065.

[28] Bao J, Guo Z, He J, Leng T, Wei Z, Wang C, et al. Semen parameters and sex hormones as affected by SARS-CoV-2 infection: A systematic review. Prog Urol 2022; 32: 1431–1439.

[29] Bendayan M, Boitrelle F. What could cause the long-term effects of COVID-19 on sperm parameters and male fertility? QJM 2021; 114: 287.

[30] Adamyan L, Elagin V, Vechorko V, Stepanian A, Dashko A, Doroshenko D, et al. COVID-19-associated inhibition of energy accumulation pathways in human semen samples. F S Sci 2021; 2: 355–364.

[31] Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone therapy in men with hypogonadism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2018; 103: 1715–1744.

[32] Pal R. COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Endocrine 2020; 68: 251–252.

[33] Apaydin T, Sahin B, Dashdamirova S, Dincer Yazan C, Elbasan O, Ilgin C, et al. The association of free testosterone levels with coronavirus disease 2019. Andrology 2022; 10: 1038–1046.

[34] Salonia A, Pontillo M, Capogrosso P, Gregori S, Tassara M, Boeri L, et al. Severely low testosterone in males with COVID-19: A case-control study. Andrology 2021; 9: 1043–1052.